Revista de la Sociedad Argentina de Diabetes (Dec 2020)

Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions

  • León Litwak,
  • Nancy Carreño,
  • Rodrigo Carnero,
  • Alejandro Dain,
  • Luis Grosembacher,
  • Carla Musso,
  • Adrián Proietti,
  • Lucas Rista,
  • Gabriela Rovira,
  • Graciela Rubin,
  • María Ruiz,
  • Antonio Saleme,
  • Liliana Trifone,
  • José Costa Gil

DOI
https://doi.org/10.47196/diab.v54i3.455
Journal volume & issue
Vol. 54, no. 3
pp. 140 – 154

Abstract

Read online

The tools to assess the degree of glycemic control were modified lately. Glycosylated Hemoglobin (HbA1c), the gold standard, reflects the glycemic control of the last 3 months retrospectively, without expressing glycemic variability. Self-blood glucose monitoring (SBGM) provides immediate and prospective information, but has little glycemic data to generate representative averages and standard deviations. It does not detect trends and has limitations to obtain nocturnal data or during physical activity. It is invasive and often rejected. On the contrary, continuous glucose monitoring (CGM), allows to measure glucose instantly, shows your trends and variability continuously, incorporating new control metrics.

Keywords